About Conference

Conference Backgroud

As the BioPharma industry grows in China & the Asian region. A part of our highly successful Biopharma series, the event, which attracts over 300 attendees, is the leading industry platform for Biopharma, biotech, Manufacturing Equipments, Bioscience and Analytical Equipments,Facility Design, Cold Chain, CMOs, CROs, Research institutes, investors,Technology and industry stakeholders to meet, network and discuss current industry trends, establish business partnerships and be updated on investment opportunities in China.

Covering topics ranging from latest regulations impacting to International partnering;from Biosimilar to CMO and Clinical development,from Protein engineering technology to Antibody development,from Biomanufacturing to Bioprocessing; from Upsteam: Cell Culture and Cell Line Development to Downstream: Protein Purification, Expression & Characterization; from Cutting edge technology & solutions to best Practice case studies;from business strategy, investment to innovation.

Snapshot of BPIC 2018:

• New investment and outlook in china biopharma industry, Biotech Innovation and regulatory compliance
• Facility Innovations In design, technology and flexibility, Innovation in technologies and manufacturing process
• Advancements on scale-up, production, purification, expression technologies, quality control
• Discuss the advanced strategy and solutions to enhance biosimilars’ bioprocessing stability and reliability
• Summarize the experience from clinical trials’ design, statistics, tests, indications and etc to quicken biosimilars’ clinical development
• Examine advances in Innovation & Technology for Biosimilar Development,Overlook the market access and clinical accessibility for future biosimilars
• Antibody & protein structure design and optimization,Leading protein and antibody engineering technology and innovational application
• Functional and Analytical Characterization of Host Cell Lines, Analytical Methods and Formulation Strategies and Technologies
• Innovative approaches and optimization in early cell line development and media
• Following up the updated R&D progress of new structural antibody, and protein under different indications

Who should attend?

More than 300 participants are expected to attend “The 3rd Biopharma Innovation Conference 2018, attracting the strong contingent throughout the Asia Pacific, USA and Europe. To breakdown, the participants will mainly come from:

By Job Title:
Chief Executives, Scientists, Directors, General Managers and Heads of:
• Antibody Research and Development
• Antibody Technology
• Immunology
• Cancer / Autoimmune Research
• Biopharmaceutical Research
• Bio-analytical science
• Regulatory affairs
• Preclinical/clinical research and development
• Biosimilars
• Licensing
• Business Development
• Antibody Purification
• Chief technology officers
• Process development
• Manufacturing
• External manufacturing/manufacturing network
• Quality assurance/quality control
• Technical operations
• Cell culture

By Industry:
•Biopharmaceutical Companies
•Vaccine/Antibody Companies
•Biotech Companies
•Manufacturing solution providers (upstream,downstream)
•Bioscience and Analytical Equipments
•Diagnostic and Testing Equipments
•Facility Design
•Protein Drug Companies
•Contract service providers (CROs, CMOs,CDMOs)
•Facility HVAC, cleanroom and containment equipment providers
•Country governments / trade agencies
•Lab Equipment Suppliers
•Legal and compliance firms
•3rd party logistics providers
•Cold chain packaging companies
•Distributors in Asia Pacifi c
•Executive search firms
•Laboratory equipment providers
•Bio Parks

Who Should Sponsor?

• Contract Manufacturing Organizations
• Contract Research Organizations
• Cell Culture and Media / Cell Lines Solutions Provider
• Disposable Technology Providers
• Purification Technology Providers
• Bioprocess Technology Providers
• Automation Technology Providers
• Process Analytical Technology (PTA) Providers
• Consultants in Process and Plant Design
• Construction and Engineering Services
• Equipment Providers
• Biologics Technology Platforms/Biotechs
• Distribution and Logistics
• Cold Chain Storage
• Regional Development Agencies
• Reagent Providers
• Packaging, Fill and Finish Service Providers
• Consultants (Law, Auditing)


World Business Forum Group is a creative business media corporate in China that leads its market in producing thought leadership, cutting edge, and technology driven summits, conferences and trade shows to clients from the Fortune 500 for their needs of high profile business networking and commercial deal making in Asia.

We also provide unrivalled expertise in analysis, market development and event management services to the global pharmaceutical, healthcare, biopharmaceutical, food and financial sectors to assist them in developing world-leading brands in China and other Asian emerging markets. We can help them achieve their commercial objectives in key areas such as market research, promotion, finding business partners and talent development as well as meeting the demands of local legislation.